(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
3 days till quarter result
(amc 2024-05-14)
Expected move: +/- 14.33%
3.75% US08948210 3.04
Live Chart Being Loaded With Signals
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases...
Stats | |
---|---|
Today's Volume | 360 207 |
Average Volume | 430 287 |
Market Cap | 32.09M |
EPS | US089482100 ( 2024-03-28 ) |
Next earnings date | ( US08948210-0.370 ) 2024-05-14 |
Last Dividend | US089482100 ( N/A ) |
Next Dividend | US089482100 ( N/A ) |
P/E | -0.760 |
ATR14 | US089482100.0160 (0.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-28 | Rehnquist Janet | Buy | 0 | |
2023-09-13 | Narido Richard Clavano | Buy | 0 | |
2023-08-30 | Gorovitz Aaron | Buy | 35 000 | Common Stock, par value $0.001 per share |
2023-08-30 | Hurvitz Chaim | Buy | 70 000 | Common Stock, par value $0.001 per share |
2023-08-23 | Javitt Jonathan C | Buy | 100 000 | Common Stock |
INSIDER POWER |
---|
4.71 |
Last 86 transactions |
Buy: 35 919 718 | Sell: 5 833 033 |
Volume Correlation
NRx Pharmaceuticals, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NRx Pharmaceuticals, Inc. Correlation - Currency/Commodity
NRx Pharmaceuticals, Inc. Financials
Annual | 2023 |
Revenue: | US089482100 |
Gross Profit: | US08948210-5 000.00 (0.00 %) |
EPS: | US08948210-3.98 |
FY | 2023 |
Revenue: | US089482100 |
Gross Profit: | US08948210-5 000.00 (0.00 %) |
EPS: | US08948210-3.98 |
FY | 2022 |
Revenue: | US089482100 |
Gross Profit: | US08948210-4 000.00 (0.00 %) |
EPS: | US08948210-0.540 |
FY | 2021 |
Revenue: | US089482100.00 |
Gross Profit: | US089482100.00 (0.00 %) |
EPS: | US08948210-7.44 |
Financial Reports:
No articles found.
NRx Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators